Annals of Internal Medicine · 2007 · 232 citations · 5 references
MedicineInfectious DiseasesPreventive MedicineInfection PreventionReproductive HealthReproductive MedicineInfectious Disease ScreeningPreventive Care For MenSexual Health PreventionSexually Transmitted Infection PreventionSexually Transmitted InfectionsWomen's Preventive CareFalse Positive Pregnancy ResultsFalse-positive ResultsInfection Risk ScreeningInfection Transmission ReductionInfection Transmission RiskPrenatal Sexually Transmitted Infection ScreeningSexually Transmitted Infection AssessmentSexually Transmitted Infection Risk Assessment
The USPSTF updated its 2001 recommendations on screening sexually active adolescents and adults for chlamydial infection. The review assessed benefits such as improved fertility and pregnancy outcomes against harms like anxiety and false‑positive treatment, based on literature from July 2000 to July 2005. The panel recommends screening all sexually active nonpregnant women ≤24 and pregnant women ≤24, plus older women at increased risk, but advises against routine screening of women ≥25 without risk and finds insufficient evidence for men. The Appendix lists the members of the USPSTF.
Description: Update of 2001 U.S. Preventive Services Task Force (USPSTF) recommendations about screening sexually active adolescents and adults for chlamydial infection. Methods: The USPSTF weighed the benefits (improved fertility, pregnancy outcomes, and infection transmission) and harms (anxiety, relationship problems, and unnecessary treatment of false-positive results) of chlamydial screening identified in their 2001 recommendations and the accompanying systematic review of English-language articles published between July 2000 and July 2005. Recommendations: Screen for chlamydial infection in all sexually active nonpregnant young women age 24 years or younger and for older nonpregnant women who are at increased risk. (A recommendation) Screen for chlamydial infection in all pregnant women age 24 years or younger and in older pregnant women who are at increased risk. (B recommendation) Do not routinely screen for chlamydial infection in women age 25 years or older, regardless of whether they are pregnant, if they are not at increased risk. (C recommendation) Current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydial infection for men. (I statement) *For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.
5
Lars Østergaard, Berit Andersen, Jens Kjølseth Møller et al. · Clinical Infectious Diseases · 2000 · 178 citations · Full text